Skip to content

13D/A filed by PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. reported 8,446,093 QCLS shares, 49.99% of the class, as of 2026-11-15, in a 13D/A accepted by EDGAR 2026-11-21 01:31:44 UTC.

Accession
0001683168-26-009020
Filed
2026-11-20
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
8,446,093
Percent of class
49.99%
Event date
2026-11-15

How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
PharmaCyte Biotech, Inc.CO8,446,09308,446,09308,446,09349.99%